Bronchial Asthma: Clinical Trials

144 trials for Bronchial Asthma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

85 completed, 30 unknown, 13 recruiting, 7 not yet recruiting. 37 Not applicable, 24 Phase 3, 21 Phase 2, 15 Phase 4, 5 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable37Completed 21, Recruiting 6, Unknown 6, Not yet recruiting 2, Terminated 1, Withdrawn 1
Phase 324Completed 17, Unknown 4, Active not recruiting 1, Not yet recruiting 1, Withdrawn 1
Phase 221Completed 10, Unknown 5, Active not recruiting 2, Recruiting 2, Enrolling by invitation 1, Withdrawn 1
Phase 415Completed 11, Unknown 3, Not yet recruiting 1
Phase 15Completed 5

Follow Bronchial Asthma: new trials by email Literature Review of Bronchial Asthma trials Research Report on Bronchial Asthma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Chromium Weight Reduction on Adult Asthma Control
Chromium picolinate - Asthma Chronic, Bronchial Asthma
Not applicableNot yet recruitingCairo University602026-08-202026-07-14
Vitamin D Status and Asthma Control, Pulmonary Function, and Oxidative Stress in Adults With Bronchial Asthma
Bronchial Asthma, Vitamin D Deficiency
Not yet recruitingSinai University1342026-07-262026-07-29
N95 Masks for Lung Health While Golfing During Wildfire Season
N95 mask - Bronchial Asthma
Not applicableRecruitingUniversity of Saskatchewan402026-05-262026-06-02
Impact of Comorbidities, Some Biomarkers, Micro RNA in Childhood Asthma Phenotypes
Short Acting Beta 2 Agonist - Bronchial Asthma
Not yet recruitingAssiut University822025-12-302025-11-17
Bioequivalence Study of AJU-R713 and R713R in Healthy Adult Volunteers
AJU-R713, R713R - Bronchial Asthma, Perennial Allergic Rhinitis
Phase 1CompletedAJU Pharm Co., Ltd.622025-12-122026-09-18
Study on the Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma
PA9159 Metered-Dose Inhaler, 120 μg per day for 28 days, Fluticasone Propionate Inhaled Aerosol 200 μg per day for 28 days - Bronchial Asthma
Phase 2RecruitingAnhui Palo Alto Pharmaceuticals, Inc.302025-10-152026-01-07
A Trial on the Treatment of Bronchial Asthma With Budesonide Formoterol Combined With Immune Modulators (Staphylococcus and Neisseria Tablets)
Budesonide Formoterol, Placebo, Immune Modulators (Staphylococcus and Neisseria Tablets) - Bronchial Asthma
Phase 3Not yet recruitingThe First Affiliated Hospital with Nanjing Medical University1982025-06-202025-06-05
Adherence to Inhaled Therapy - a Globally Overlooked Problem in Patients With Chronic Obstructive Pulmonary Disease and Bronchial Asthma
Education in inhalation technique - Chronic Obstructive Pulmonary Disease (COPD), Bronchial Asthma
Not applicableRecruitingCharles University, Czech Republic10002025-06-032025-09-30
Study of MG-ZG122 Humanized Monoclonal Antibody in Asthma Subjects
MG-ZG122 Humanized Monoclonal Antibody Injection, Placebo - Bronchial Asthma
Phase 2Active not recruitingShanghai Mabgeek Biotech.Co.Ltd1602025-05-112025-07-08
The Use of Entropy to Assess Sleep Disordered Breathing in Chronic Respiratory Disease
Bronchial Asthma, Bronchiectasis
RecruitingUniversity College, London1202025-04-302025-07-11
Evaluation of Clinical Effect of Acupuncture on Acute Exacerbation of Bronchial Asthma
Acupuncture, Standard Western medicine treatment - Bronchial Asthma
Not applicableRecruitingHenan University of Traditional Chinese Medicine722025-04-152026-06-08
Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma
PA9159 Metered-Dose Inhaler, 60 μg per day for 28 days, PA9159 Metered-Dose Inhaler, 120 μg per day for 28 days, PA9159 Metered-Dose Inhaler, 240 μg per day for 28 days - Bronchial Asthma
Phase 2RecruitingAnhui Palo Alto Pharmaceuticals, Inc.602025-02-242026-01-08
Community Exercise Treating Effect on Cardiopulmonary Disease Patients
community-based exercise training - Coronary Heart Disease (CHD), Heart Failure
Not applicableRecruitingGuangdong Provincial People's Hospital2002025-01-302025-09-04
Bronchial Asthma & Its Exacerbation
Bronchial Asthma
UnknownAssiut University502025-01-012024-03-26
Oral Intake of Mg in Controlled Asthmatic Patients
Magnesium, ICS+LABA - Bronchial Asthma
Phase 2 / Phase 3Active not recruitingZagazig University1662024-11-022025-08-14
A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Bronchial Asthma
HSK31858, Placebo - Bronchial Asthma
Phase 2Enrolling by invitationHaisco Pharmaceutical Group Co., Ltd.2192024-10-222024-12-24
Echo and Electrocardiographic Findings in Children With Bronchial Asthma At Sohag University Hospital
Echocardiography, Electrocardiography - Bronchial Asthma
Not applicableNot yet recruitingSohag University302024-10-012024-10-15
FeNO Detection in Asthma Diagnosis: A New Technology Approach
Chemiluminescent FeNO Analyzer, Electrochemical FeNO Analyzer - Bronchial Asthma, Airway Disease
Not applicableRecruitingNovlead Inc.1702024-09-122025-02-28
Effect of Multimedia Protocol About Asthma Control
Multimedia Protocol about Asthma Control - Bronchial Asthma, Childhood Asthma
Not applicableCompletedMansoura University652024-09-012026-10-08
A Study of Step-up in Bronchial Asthma as a New End Point in Asthma Control (SURFE)
Bronchial Asthma
UnknownAin Shams University1002024-08-212024-09-19

Showing 20 of 144. Sign in to see all of them.

Narrower conditions

Asthma (144)  ·  Pulmonary Disease, Chronic Obstructive (10)  ·  Hypersensitivity (6)  ·  Bronchiectasis (3)  ·  Cystic Fibrosis (3)  ·  Lung Diseases, Interstitial (3)  ·  Signs and Symptoms, Respiratory (3)  ·  Bronchial Hyperreactivity (2)  ·  Coronary Disease (2)  ·  Inflammation (2)  ·  Medication Adherence (2)  ·  Pulmonary Eosinophilia (2)  ·  Respiratory Aspiration (2)  ·  Rhinitis, Allergic (2)  ·  Sleep Apnea, Obstructive (2)

Broader conditions

Hypersensitivity, Immediate (144)  ·  Lung Diseases, Obstructive (144)  ·  Respiratory Hypersensitivity (144)  ·  Respiratory Tract Diseases (144)  ·  Bronchial Diseases (143)  ·  Immune System Diseases (143)  ·  Lung Diseases (143)  ·  Hypersensitivity (138)  ·  Pathological Conditions, Signs and Symptoms (21)  ·  Pathologic Processes (15)  ·  Chronic Disease (10)  ·  Disease Attributes (10)  ·  Respiration Disorders (7)  ·  Hemic and Lymphatic Diseases (6)  ·  Signs and Symptoms (6)

Interventions

Albuterol (6)  ·  Budesonide (5)  ·  Beclomethasone (4)  ·  Budesonide, Formoterol Fumarate Drug Combination (4)  ·  montelukast (4)  ·  Fluticasone (3)  ·  Carbamazepine (2)  ·  Fluticasone-Salmeterol Drug Combination (2)  ·  Formoterol Fumarate (2)  ·  Omalizumab (2)  ·  Plethysmography, Whole Body (2)  ·  Probiotics (2)  ·  Roflumilast (2)  ·  Spirometry (2)  ·  Tacrolimus (2)

Sponsors

AstraZeneca (12)  ·  Centre of Chinese Medicine, Georgia (8)  ·  Assiut University (6)  ·  Cairo University (6)  ·  Sohag University (6)  ·  Chiesi Farmaceutici S.p.A. (4)  ·  Medical University of Lodz (4)  ·  Shanghai University of Traditional Chinese Medicine (4)  ·  Universitätsmedizin Mannheim (4)  ·  Anhui Palo Alto Pharmaceuticals, Inc. (3)  ·  Carmel Medical Center (3)  ·  Cipla Ltd. (3)  ·  GlaxoSmithKline (3)  ·  Henan University of Traditional Chinese Medicine (3)  ·  Ain Shams University (2)

Countries

China (22)  ·  Egypt (15)  ·  Germany (11)  ·  Japan (10)  ·  Poland (10)  ·  Russia (9)  ·  Czechia (7)  ·  United Kingdom (7)  ·  United States (7)  ·  India (6)  ·  Ukraine (6)  ·  Israel (4)  ·  Italy (4)  ·  Saudi Arabia (4)  ·  Bulgaria (3)

Top investigators

Manana Tchaia, MD (6)  ·  Merab Lomia, MD, PhD (6)  ·  Tamara Tchelidze, MD (4)  ·  Haim Bibi, MD (3)  ·  Entsar H Mohamed, Lecturer (2)  ·  Leonardo M. Fabbri, MD (2)  ·  Maurizio A. Vignola, MD (2)  ·  Merab Lomia, MD (2)  ·  Stefan Zielen, M.D., Ph.D. (2)  ·  Tomas Andersson, MD (2)  ·  Wei Zuo (2)  ·  Yoshida Shigeru, MD (2)  ·  Zhenhui Lu, Doctor (2)

Results publications

PMID 11113827, PMID 11163535, PMID 11728816, PMID 11825832, PMID 14709423, PMID 15080825, PMID 16597501, PMID 17107988, PMID 17845589, PMID 19772514, PMID 20522464, PMID 20637584, PMID 21859484, PMID 22221427, PMID 22394648, PMID 22496329, PMID 2398607, PMID 24337046, PMID 24506412, PMID 25485197, PMID 25640020, PMID 25907171, PMID 27824606, PMID 28544140, PMID 28757156, PMID 28824451, PMID 29228942, PMID 29548297, PMID 29554195, PMID 29973284, PMID 30049739, PMID 30453867, PMID 30461531, PMID 30881051, PMID 31277742, PMID 32050956, PMID 32347992, PMID 32509795, PMID 32994855, PMID 33095411, PMID 33329598, PMID 33515429, PMID 35648804, PMID 36472162, PMID 37805024, PMID 39112964, PMID 39710171, PMID 40029906, PMID 40665411, PMID 42548535

NIH funding

2009 (1), P50AT002782 (1)